I agree with your take on additional financing. They will enroll approximately 500 patients in the frontline trial. That's less than I expected. By the time they begin this trial we will know more about 113. If they need more money to advance the pipeline - that's good news IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.